However, cumulative findings from observational studies and more recent randomized controlled trials have demonstrated that overall delays in ART initiation are associated with increased mortality among TB patients across a wide spectrum of baseline CD4 cell counts [4-7]. This evidence concerns the gene CD4 and tuberculosis.